Crescendo Bioscience

Crescendo Bioscience, Inc. develops quantitative and objective diagnostic tools to provide rheumatologists with clinical insights to manage patients with autoimmune and inflammatory diseases. It provides diagnostic, prognostic, staging, therapy selection, and monitoring facilities to physicians. Crescendo Bioscience, Inc. was formerly known as Riley Genomics, Inc. The company was founded in 2002 and is based in South San Francisco, California.

Crescendo Bioscience headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical sector. The company focuses on Biotechnology and has secured $10.2B in funding across 72 round(s). With a team of 51-100 employees, Crescendo Bioscience is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Crescendo Bioscience, raised $37.6M. Discover more about their projects, partnerships, and impact on our platform.